Progressive Clinical Research

Your Clinical Trials Leader
Home
About Us
Contact Us
Privacy Policy
Site Map

 

Now Enrolling

 

We Are Currently Seeking Qualified Participants in the Following Clinical Trials:

  • Diabetes with High Blood Pressure

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects with Type 2 Diabetes with inadequately controlled hypertension treated with an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) with or without an additional Antihypertensive medication

  • Diabetes for patients who take Metformin

A Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Multicenter

Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment

of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on

Metformin Monotherapy

  • Post MI (Heart Attack)

A randomized, double-blind, placebo-controlled, event-driven trial of quarterly subcutaneous canakinumab in the

prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with elevated

hsCRP

  • High Cholesterol

A randomized, double-blind, parallel-group, placebo-controlled, multicenter study evaluating the efficacy and safety of five doses and two dose regimens of SAR236553 over 12 weeks in patients with primary hypercholesterolemia and LDL-cholesterol > 100 mg/dl (> 2.59 mmol/L) on ongoing stable atorvastatin therapy

  • Diabetes for patients who are not on any curreent medications

A Phase IIb, Randomized, Placebo-Controlled, Dose-Range Finding Clinical Trial to Study the Safety and Efficacy of MK-3102 in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control

  • Gout

A randomized, double-blind, active-controlled study of canakinumab (ACZ885) pre-filled syringes or reconstituted lyophilizate versus triamcinolone acetonide for treating acute gouty arthritis flares in frequently flaring patients

 

  • Overactive Bladder

A Phase llb Randomized, Placebo- and Active Comparator (Tolterodine)-Controlled, 2 Part Clinical Study of the Efficacy and Safety of MK-4618 in Patients with Overactive Bladder

                                                                                                                      

 

 

We are a multi-specialty research organization.  We conduct clinical trials in areas of hypertension, diabetes, pain management, hyperlipidemia, neurology, infections, asthma, allergy, arthritis and more.  We have a site-based quality assurance program which allows us to not only achieve quality, but to continuously improve it.

 

Located in the foothills of Bountiful, Utah. Just a few steps from Lakeview Hospital and many local restaurants and business offices.

425 South 650 East (Medical Drive) Suite 117 Bountiful, Utah 84010
Driving Directions
Click the map to open an interactive map in a new window.